NCT03458234 RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy Status TERMINATED Phase NA
NCT03445559 A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging Status ACTIVE_NOT_RECRUITING Phase NA
NCT03444844 Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03441464 Feasibility of the LUM Imaging System for Detection of Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03440879 Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose Status TERMINATED Phase NA
NCT03440554 Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization Status UNKNOWN Phase NA
NCT03439033 Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer Status TERMINATED Phase PHASE2
NCT03436654 Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03432897 BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes Status TERMINATED Phase PHASE2
NCT03431753 Early and Accurate Detection of Prostate Cancer in General Practice Status UNKNOWN Phase NA
NCT03429244 PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer Status COMPLETED Phase PHASE2
NCT03424850 Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy Status RECRUITING Phase PHASE1/PHASE2
NCT03424694 HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer Status COMPLETED Phase NA
NCT03424213 Race-related Alternative Splicing: Novel Targets in Prostate Cancer Status COMPLETED Phase N/A
NCT03423927 Benefits of an Intervention Combining Hypnosis and Self-care for Prostate Cancer Patients Status COMPLETED Phase NA